MW Creators

World News

Community-Acquired Bacterial Pneumonia (CABP) Market is Expected to Showcase Significant Growth by 2030, Predicts DelveInsight | Key Companies – Paratek Pharma, Melinta Therapeutics, and Others

DelveInsight’s “Community-Acquired Bacterial Pneumonia (CABP) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia (CABP) market trends in the seven major markets (7MM) (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The market report covers emerging drugs, current treatment practices, market share of the individual therapies, market drivers, barriers, unmet medical needs, current and forecasted market size from 2017 to 2030 segmented by seven major markets. 

Community-Acquired Bacterial Pneumonia (CABP) Disease Overview

According to Steel et al. (n.d.), community-acquired pneumonia (CAP) is described as an acute infection of the lung parenchyma acquired in the community. It is most commonly bacterial in nature and is associated with clinical and/or radiological evidence of consolidation of part or parts of one or both lungs. The most commonly identified pathogens are Streptococcus pneumoniae, Haemophilus influenzae, a typical bacteria (i.e., Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella sp).

Community-Acquired Bacterial Pneumonia (CABP) Market Key Facts

  • According to the European Lung White Book, approximately 3,370,000 cases of CAP are reported annually in the European Union with 1 million hospitalizations. Furthermore, the adult incidence of CAP in Europe ranges from 1.7–11.6 cases/1,000 people/year.
  • The Center for Disease Control and Prevention (CDC) estimates that drug-resistant bacteria causes 2 million illnesses and approximately 23,000 deaths each year in the United States. The main bacteria causing CABP (Streptococcus pneumonia), is responsible for 1.2 million infections and 7,000 deaths annually.
  • Many studies have suggested that the incidence of CAP is slightly higher in males as compared to females.
  • Niederman and Bender (2016) suggested that the mortality rate of CAP is around 8.8% during the study period of 1995–2015. This study has also reported a mortality rate of 4.5% in cases from18–44 years age group while 12.5% in those over age 65.


Key Benefits of Community-Acquired Bacterial Pneumonia (CABP) Market Report

  • The market report provides an in-depth analysis of Community-Acquired Bacterial Pneumonia (CABP) Market size, share, and epidemiology in 7MM.
  • The report will help in developing business strategies by understanding the trends & developments, key players operating in the market, and future competition that will drive and shape the market outlook in the upcoming years.
  • The report covers the factors stimulating the Community-Acquired Bacterial Pneumonia (CABP) market growth, current treatment practices, emerging drugs, market share of the individual therapies.
  • The report provides a detailed assessment of the patient population, unmet needs, comparative analysis of pipeline products with detailed clinical profiles, and other factors. 


Community-Acquired Bacterial Pneumonia (CABP) Market

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Community-Acquired Bacterial Pneumonia (CABP) market size and share by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology. 

The report gives a thorough detail of market trends, growth opportunities of each marketed and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Visit to get more detailed insights @

Community-Acquired Bacterial Pneumonia (CABP) Epidemiology

The epidemiology section covers insights about historical and current Community-Acquired Bacterial Pneumonia (CABP) patient pool and forecasted trends for every seven major markets from 2017 to 2030. It helps to recognize the causes of current and forecasted Community-Acquired Bacterial Pneumonia (CABP) epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Discover more about the epidemiological segmentation @

Community-Acquired Bacterial Pneumonia (CABP) Drugs Uptake and Key Market Players

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Community-Acquired Bacterial Pneumonia (CABP) market or expected to get launched in the market during the study period. The analysis covers the drug uptake; patient uptake by therapies; and sales of each drug.   

 Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Community-Acquired Bacterial Pneumonia (CABP) Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent development such as collaborations, acquisitions, and mergers, licensing patent details, and other information.

Community-Acquired Bacterial Pneumonia (CABP) Therapeutics Analysis

The dynamics of community-acquired Bacterial Pneumonia (CABP) market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and expected launch of emerging therapies.

Some of the key players in the Community-Acquired Bacterial Pneumonia (CABP) market include:

  • Paratek Pharmaceuticals
  • Melinta Therapeutics

And many others

Community-Acquired Bacterial Pneumonia (CABP) Therapies covered in the report includes:

  • Nuzyra
  • Baxdela

And many others.

For further information about the emerging therapies and key companies @


Table of Content

  1. Key Insights
  2. Executive Summary 
  3. Community-Acquired Bacterial Pneumonia (CABP) Competitive Intelligence Analysis
  4. Community-Acquired Bacterial Pneumonia (CABP) Market Overview at a Glance
  5. Community-Acquired Bacterial Pneumonia (CABP) Disease Background and Overview
  6. Community-Acquired Bacterial Pneumonia (CABP) Patient Journey
  7. Community-Acquired Bacterial Pneumonia (CABP) Epidemiology and Patient Population
  8. Community-Acquired Bacterial Pneumonia (CABP) Treatment Algorithm, Current Treatment, and Medical Practices
  9. Community-Acquired Bacterial Pneumonia (CABP) Unmet Needs
  10. Key Endpoints of Community-Acquired Bacterial Pneumonia (CABP) Treatment
  11. Community-Acquired Bacterial Pneumonia (CABP) Marketed Products
  12. Community-Acquired Bacterial Pneumonia (CABP) Emerging Therapies
  13. Community-Acquired Bacterial Pneumonia (CABP) Seven Major Market Analysis
  14. Attribute Analysis
  15. Community-Acquired Bacterial Pneumonia (CABP) Market Outlook (7 major markets)
  16. Community-Acquired Bacterial Pneumonia (CABP) Access and Reimbursement Overview
  17. KOL Views on the Community-Acquired Bacterial Pneumonia (CABP) Market.
  18. Community-Acquired Bacterial Pneumonia (CABP) Market Drivers
  19. Community-Acquired Bacterial Pneumonia (CABP) Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get a Free Sample Copy of the Report @

Latest Reports By DelveInsight:

Community-Acquired Bacterial Pneumonia (CABP) Epidemiology Forecast

DelveInsight’s Community-Acquired Bacterial Pneumonia (CABP) Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Community-Acquired Bacterial Pneumonia (CABP) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Community-Acquired Bacterial Pneumonia (CABP) Pipeline Insights

Community-Acquired Bacterial Pneumonia (CABP) Pipeline Insight, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Community-Acquired Bacterial Pneumonia (CABP) market.

Total Knee Arthroplasty Market

DelveInsight’s ‘Total Knee Arthroplasty -Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of Total Knee Arthroplasty and the historical and forecasted Total Knee Arthroplasty market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.

Latest Healthcare Blogs By DelveInsight:


About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Info:
Shruti Thakur
DelveInsight Business Research LLP
Phone No: +91-9650213330
Email: [email protected]
Connect With Us: LinkedIn | Facebook | Twitter
For Latest Update: Healthcare Blog
Request for Sample Copy of the Report at:

Leave a Reply

Your email address will not be published. Required fields are marked *